Hudson Executive Capital LP Diversified Active

CIK: 0001652522 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $338,998 (100.0% shares, 0.0% debt)

Holdings (7)

— CARDTRONICS PLC 42.0%

Value ($000) $142,512 Shares 6,387,830 Est. Cost $21.16 Unrealized —

EGRX EAGLE PHARMACEUTICALS INC 15.1%

Value ($000) $51,162 Shares 971,000 Est. Cost $46.78 Unrealized +24.3%

ATRC ATRICURE INC 14.4%

Value ($000) $48,717 Shares 2,374,119 Est. Cost $17.42 Unrealized +3.6%

— CIT GROUP INC 12.9%

Value ($000) $43,855 Shares 851,557 Est. Cost $37.71 Unrealized —

— ACORDA THERAPEUTICS INC 9.2%

Value ($000) $31,140 Shares 1,316,700 Est. Cost $20.62 Unrealized —

— CORINDUS VASCULAR ROBOTICS I 4.6%

Value ($000) $15,531 Shares 11,336,154 Est. Cost $1.31 Unrealized —

— FCB FINL HLDGS INC 1.8%

Value ($000) $6,081 Shares 119,000 Est. Cost $50.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CARDTRONICS PLC	6,387,830	$142,512	42.0%	$21.16	—	SHS CL A	G1991C105
EGRX	EAGLE PHARMACEUTICALS INC	971,000	$51,162	15.1%	$46.78	+24.3%	COM	269796108
ATRC	ATRICURE INC	2,374,119	$48,717	14.4%	$17.42	+3.6%	COM	04963C209
—	CIT GROUP INC	851,557	$43,855	12.9%	$37.71	—	COM NEW	125581801
—	ACORDA THERAPEUTICS INC	1,316,700	$31,140	9.2%	$20.62	—	COM	00484M106
—	CORINDUS VASCULAR ROBOTICS I	11,336,154	$15,531	4.6%	$1.31	—	COM	218730109
—	FCB FINL HLDGS INC	119,000	$6,081	1.8%	$50.99	—	CL A	30255G103